Endocrinology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e130-e139. doi: 10.1210/clinem/dgaa695.
Cushing's syndrome frequently causes mental health impairment. Data in patients with adrenal incidentaloma (AI) are lacking.
We aimed to evaluate psychiatric and neurocognitive functions in AI patients, in relation to the presence of subclinical hypercortisolism (SH), and the effect of adrenalectomy on mental health.
We enrolled 62 AI patients (64.8 ± 8.9 years) referred to our centers. Subclinical hypercortisolism was diagnosed when cortisol after 1mg-dexamethasone suppression test was >50 nmol/L, in the absence of signs of overt hypercortisolism, in 43 patients (SH+).
The structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders-5, and 5 psychiatric scales were performed. The Brief Assessment of Cognition in Schizophrenia (Verbal and Working Memory, Token and Symbol Task, Verbal Fluency, Tower of London) was explored in 26 patients (≤65 years).
The prevalence of psychiatric disorders was 27.4% (SH+ 30.2% vs SH- 21.1%, P = 0.45). SH+ showed a higher prevalence of middle insomnia (by the Hamilton Depression Rating Scale) compared with SH- (51% vs 22%, P = 0.039). Considering the Sheehan Disability Scale, SH+ showed a higher disability score (7 vs 3, P = 0.019), higher perceived stress (4.2 ± 1.9 vs 2.9 ± 1.9, P = 0.015), and lower perceived social support (75 vs 80, P = 0.036) than SH-. High perceived stress was independently associated with SH (odds ratio [OR] = 5.46, confidence interval 95% 1.4-21.8, P = 0.016). Interestingly, SH+ performed better in verbal fluency (49.5 ± 38.9 vs 38.9 ± 9.0, P = 0.012), symbol coding (54.1 ± 6.7 vs 42.3 ± 15.5, P = 0.013), and Tower of London (15.1 vs 10.9, P = 0.009) than SH-. In 8 operated SH+, no significant changes were found.
Subclinical hypercortisolism may influence patients' mental health and cognitive performances, requiring an integrated treatment.
库欣综合征常导致精神健康受损。有关肾上腺意外瘤(AI)患者的数据尚缺乏。
我们旨在评估 AI 患者的精神和神经认知功能,同时评估亚临床皮质醇增多症(SH)的存在,以及肾上腺切除术对心理健康的影响。
我们纳入了 62 名 AI 患者(64.8±8.9 岁),他们被转至我们的中心。SH 的诊断标准为:在 1mg 地塞米松抑制试验后,皮质醇>50nmol/L,同时无显性皮质醇增多症的迹象,共有 43 名患者(SH+)符合这一标准。
我们对这些患者进行了《精神障碍诊断与统计手册-5》的结构性临床访谈和 5 项精神科量表评估。对 26 名(≤65 岁)患者进行了简短的精神分裂症认知评估(言语和工作记忆、符号和符号任务、言语流畅性、伦敦塔)。
精神障碍的患病率为 27.4%(SH+为 30.2%,SH-为 21.1%,P=0.45)。与 SH-相比,SH+的中间失眠(汉密尔顿抑郁评定量表)更为常见(51%比 22%,P=0.039)。在 Sheehan 残疾量表中,SH+的残疾评分更高(7 分比 3 分,P=0.019),感知压力更大(4.2±1.9 比 2.9±1.9,P=0.015),感知社会支持更小(75 比 80,P=0.036)。与 SH-相比,SH+在言语流畅性(49.5±38.9 比 38.9±9.0,P=0.012)、符号编码(54.1±6.7 比 42.3±15.5,P=0.013)和伦敦塔(15.1 比 10.9,P=0.009)方面表现更好。在 8 名接受手术的 SH+患者中,未发现明显变化。
亚临床皮质醇增多症可能会影响患者的心理健康和认知表现,需要进行综合治疗。